• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[粒细胞-巨噬细胞集落刺激因子/白细胞介素-3对脐血CD34+造血祖细胞移植效率的影响]

[The effect of GM-CSF/IL-3 on the grafting efficiency of CD34+ hemopoietic progenitor cells from umbilical cord blood].

作者信息

Pei X T, Wu Z Z, Coutinho L H, Testa N G, Dexter T M

机构信息

Beijing Institute of Radiation Medicine.

出版信息

Sheng Li Xue Bao. 1995 Oct;47(5):485-90.

PMID:8711513
Abstract

CD34+ cells were isolated from human umbilical cord blood by using a high-gradient magnetic cell sorting system with anti-CD34 monoclonal antibody coated with microbeads, and then inoculated onto a pre-formed irradiated bone marrow stroma to evaluate the grafting efficiency of CD34+ cells with rhGM-CSF or IL-3, alone or in combination. The results showed that only 36% CD34+ cells in the control, and 68 - 89.6% in the groups with growth factors treatment seeded to the stroma. A short incubation of CD34+ cells with growth factors could rapidly reconstitute a long-term hemopoiesis in the long-term liquid culture system. This demonstrates that a brief treatment of CD34+ cells with GM-CSF or IL-3 can improve the grafting efficiency of transplanted umbilical cord blood cells.

摘要

使用包被有抗CD34单克隆抗体微珠的高梯度磁性细胞分选系统从人脐带血中分离出CD34+细胞,然后接种到预先照射过的骨髓基质上,以评估单独或联合使用重组人粒细胞巨噬细胞集落刺激因子(rhGM-CSF)或白细胞介素-3(IL-3)时CD34+细胞的植入效率。结果显示,对照组中只有36%的CD34+细胞接种到了基质上,而在生长因子处理组中这一比例为68%-89.6%。CD34+细胞与生长因子短暂孵育能够在长期液体培养系统中快速重建长期造血功能。这表明用GM-CSF或IL-3对CD34+细胞进行短暂处理可以提高移植脐带血细胞的植入效率。

相似文献

1
[The effect of GM-CSF/IL-3 on the grafting efficiency of CD34+ hemopoietic progenitor cells from umbilical cord blood].[粒细胞-巨噬细胞集落刺激因子/白细胞介素-3对脐血CD34+造血祖细胞移植效率的影响]
Sheng Li Xue Bao. 1995 Oct;47(5):485-90.
2
[Experimental studies on the expansion of cord blood CD34+ cells and the improvement of their grafting efficiency].脐血CD34+细胞扩增及其移植效率提高的实验研究
Zhonghua Xue Ye Xue Za Zhi. 1997 Mar;18(3):133-6.
3
Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.高效基因转移至早产CD34造血祖细胞。
Am J Obstet Gynecol. 2000 Sep;183(3):732-7. doi: 10.1067/mob.2000.106752.
4
Effects of recombinant cytokines on colony formation by irradiated human cord blood CD34+ hematopoietic progenitor cells.重组细胞因子对经辐照的人脐带血CD34+造血祖细胞集落形成的影响。
Radiat Res. 1997 Jan;147(1):61-9.
5
Extensive amplification of single cells from CD34+ subpopulations in umbilical cord blood and identification of long-term culture-initiating cells present in two subsets.脐血中CD34+亚群单细胞的广泛扩增以及两个亚群中存在的长期培养起始细胞的鉴定。
Stem Cells. 1996 Sep;14(5):566-76. doi: 10.1002/stem.140566.
6
Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.由粒细胞集落刺激因子(G-CSF)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)或两者联合动员的白细胞分离产物中的多能和定向分化CD34+亚群。
Exp Hematol. 1996 Nov;24(13):1460-8.
7
Synergistic effects of hepatocyte growth factor on human cord blood CD34+ progenitor cells are the result of c-met receptor expression.肝细胞生长因子对人脐血CD34+祖细胞的协同作用是c-met受体表达的结果。
Stem Cells. 1996 Sep;14(5):592-602. doi: 10.1002/stem.140592.
8
Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.利用重组生长因子扩增人脐带血CD34+造血祖细胞
Prog Clin Biol Res. 1994;389:399-404.
9
Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.巨核细胞祖细胞的体外扩增:多种生长因子组合对来自骨髓和粒细胞集落刺激因子动员的外周血的CD34+祖细胞的影响。
Exp Hematol. 1997 Oct;25(11):1125-39.
10
High efficiency electroporation of human umbilical cord blood CD34+ hematopoietic precursor cells.人脐带血CD34+造血前体细胞的高效电穿孔
Stem Cells. 2001;19(6):492-9. doi: 10.1634/stemcells.19-6-492.

引用本文的文献

1
Stem cell engineering: the new generation of cellular therapeutics.干细胞工程:新一代细胞疗法。
Int J Hematol. 2002 Aug;76 Suppl 1:155-6. doi: 10.1007/BF03165233.